400
Participants
Start Date
April 30, 2006
Primary Completion Date
January 31, 2007
Study Completion Date
January 31, 2007
Inhaled Placebo
Inhaled Staccato Placebo
Inhaled PCZ 5 mg
Inhaled Staccato Prochlorperazine 5 mg
Inhaled PCZ 7.5 mg
Inhaled Staccato Prochlorperazine 7.5 mg
Inhaled PCZ 10 mg
Inhaled Staccato Prochlorperazine 10 mg
New York Headache Center, New York
Elkind Headache Center, Mount Vernon
Island Neurological Associates, PC, Plainview
Regional Clinical Research, Endwell
PharmQuest, Greensboro
MD Clinical, Hallandale
Palm Beach Neurological Center, West Palm Beach
Health Research Associates, Cleveland
ClinExcel Research, West Chester
Headache Care Center Primary Care Network, INC, Springfield
University Neurologists/OUHSC, Oklahoma City
Houston Headache Clinic, Houston
Department of Neurology, Mayo Clinic, Scottsdale
California Medical Clinic for Headache, Santa Monica
San Francisco Headache Clinic, San Francisco
Neurological Research Institute of East Bay, Walnut Creek
Swedish Research Center, Seattle
Mile High Research Center, Denver
Associated Neurologists of Southern Connecticut PC, Fairfield
Hartford Headache Center, Hartford
The New England Center for Headache, Stamford
Diamond Headache Clinic, Chicago
Medvadis, Wellesley Hills
New England Regional Headache Center, Worcester
The Michigan Head-Pain and Neurological Institute, Ann Arbor
Lead Sponsor
Alexza Pharmaceuticals, Inc.
INDUSTRY